Cost analysis of real-time polymerase chain reaction microbiological diagnosis in patients with septic shock

Anaesthesia and Intensive Care

Volumn 40, Issue 6, 2012, Pages 958-963

  Alvarez, Julian ^a,b   Mar, J ^a,c   Varela Ledo, E ^a,b   Garea, M ^a,b   Matinez Lamas, L ^a,b   Rodriguez, J ^a,b   Regueiro, B ^a,b  

^a University Hospitals   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

^c Hospital Alto Deba   (Spain)

Author keywords

Microbiological diagnosis; Septic shock; Severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK; COMPARATIVE STUDY; COST; ECONOMICS; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COSTS AND COST ANALYSIS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC;

EID: 84871867383     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000606     Document Type: Article

References (28)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310.
2. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003; 168:165-172.
3. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31:2332-2338.
4. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
5. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474.
6. Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Methicillin-resistant Staphylococcus aureus sterile-site infection:The importance of appropriate initial antimicrobial treatment.Crit Care Med 2006; 34:2069-2074.
7. Harbarth S, Garbino J, Pugin J, Romand J, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-535.
8. Andrade SS, Bispo PJM, Gales AC. Advances in the microbiological diagnosis of sepsis. Shock 2008; 30 (Suppl 1):41-46.
9. Lehmann LE, Alvarez J, Hunfeld K-P, Goglio A, Kost GJ, Louie RF et al. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 2009; 37:3085-3090.
10. Regueiro BJ, Varela-Ledo E, Martinez-Lamas L, Rodriguez-Calvino J, Aguilera A, Santos A et al. Automated extraction improves multiplex molecular detection of infection in septic patients. PLoS One 2010; 5:e13387.
11. Lehmann LE, Herpichboehm B, Kost GJ, Kollef MH, Stuber F. Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care 2010; 14:R186.
12. Fang C, Otero HJ, Greenberg D, Neumann PJ. Cost-utility analyses of diagnostic laboratory tests: a systematic review. Value Health 2011; 14:1010-1018.
13. Diagnostics Assessment Programme manual. National Institute for Health and Clinical Excellence. Manchester 2011.
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
15. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-555.
16. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256.
17. Lehmann LE, Hunfeld K-P, Emrich T, Haberhausen G, Wissing H, Hoeft A et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008; 197:313-324.
18. McGuire A. Theoretical concepts in the economic evaluations of health care. In: Drummond M, McGuire A, eds. Economic evaluation in health care. Merging theory with practice. Oxford: Oxford University Press 2001.
19. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Cost analysis. In: Drummond MF ed. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press 1997. p. 52-95.
20. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press 1996.
21. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997; 6:327-340.
22. MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med 2008; 36:3184-3189.
23. Sacristan JA, Prieto L, Huete T, Artigas A, Badia X, Chinn C et al. [Cost-effectiveness of drotrecogin alpha [activated] in the treatment of severe sepsis in Spain]. Gac Sanit 2004; 18:50-57.
24. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
25. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
26. Mancini N, Carletti S, Ghidoli N, Cichero P, Ossi CM, Ieri R et al. Molecular diagnosis of polymicrobial sepsis. J Clin Microbiol 2009; 47:1274-1275.
27. Leone M, Martin C. How to break the vicious circle of antibiotic resistances? Curr Opin Crit Care 2008; 14:587-592.
28. Eagye KJ, Nicolau DP, Lockhart SR, Quinn J, Doern G, Gallagher G et al. A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004. Ann Clin Microbiol Antimicrob 2007; 6:11-17.